Findings

What do systematic reviews say?

466 questions · 492 findings · 33 reviews · Common Mental Disorders

Sort:Best matchNewest Highest certainty Download CSV

No studies found 136 · 27.6%GRADE not reported 7 · 1.4%Very low 147 · 29.9%Low 133 · 27%Moderate 58 · 11.8%High 11 · 2.2%

Intervention not reported

Cost‐effectiveness of interventions · adults or children of all ethnicities

The review found no eligible studies for this question.

1 finding from 1 review

Means restriction for the prevention of suicide by jumping 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Cost‐effectiveness of interventions · adults or children of all ethnicities

The review found no eligible studies for this question.

1 finding from 1 review

Means restriction for the prevention of suicide by jumping 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Cost‐effectiveness of interventions (the study reviewed suicide data from a bridge and surrounding areas over a 70‐year period, and estimated reductions in mortality due to the barrier over a 20‐year period) · adults or children of all ethnicities

1 finding from 1 review

Means restriction for the prevention of suicide by jumping 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
Low

Intervention not reported

Cost‐effectiveness of interventions · adults or children of all ethnicities

The review found no eligible studies for this question.

1 finding from 1 review

Means restriction for the prevention of suicide by jumping 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Cost‐effectiveness of interventions · adults or children of all ethnicities

The review found no eligible studies for this question.

1 finding from 1 review

Means restriction for the prevention of suicide by jumping 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Propranolol vs placebo

Treatment efficacy CAPS, CIDI · adult participants (18 years and older) who have been exposed to any traumatic events, but who did not meet the diagnostic criteria for…

Propranolol showed no clear difference in treatment efficacy CAPS, CIDI compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD) 2014 · Cochrane Headline outcomes only
RR 0.62 [0.24, 1.59]
3 studies · 118 participants
Low

Hydrocortisone vs placebo

Treatment efficacy CAPS, SCID‐IV, PTSS‐10Q‐I · adult participants (18 years and older) who have been exposed to any traumatic events, but who did not meet the diagnostic criteria for…

Hydrocortisone probably leads to lower treatment efficacy CAPS, SCID‐IV, PTSS‐10Q‐I compared with placebo (moderate certainty).

1 finding from 1 review

Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD) 2014 · Cochrane Headline outcomes only
RR 0.17 [0.05, 0.56]
4 studies · 165 participants
Moderate

Tricyclic antidepressants vs placebo

Severity/intensity of MUPS (post‐treatment score on self report scales) Different self report and clinician‐rated scales (SOMS‐7, SCL‐90 Somatisation Score) · somatoform disorders in adults

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 239 participants
Low

New‐generation antidepressants vs placebo

Anxiety · somatoform disorders in adults

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 163 participants
Very low

New‐generation antidepressants vs placebo

Endpoint score (HDRS or MADRS) · somatoform disorders in adults

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 163 participants
Very low

New‐generation antidepressants vs placebo

Withdrawals due to adverse events · somatoform disorders in adults

New‐generation antidepressants showed no clear difference in adverse effects (drop‐outs due to adverse effects) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
RR 2.26 [0.52, 9.81]
2 studies · 163 participants
Low

New‐generation antidepressants vs placebo

Treatment response (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults

It is very uncertain whether new‐generation antidepressants changes treatment response (post‐treatment score on self report and… compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
RR 2 [0.9, 4.43]
2 studies · 163 participants
Very low

New‐generation antidepressants vs placebo

Quality of life at post‐treatment Indexed by self‐report measures of quality of life or functional disability · somatoform disorders in adults

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 163 participants
Very low

Natural products vs placebo

Severity/intensity of MUPS (post‐treatment score on self report scales) Different self report and clinician‐rated scales (SOMS‐7, SCL‐90 Somatisation Score) · somatoform disorders in adults

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 322 participants
Low

Natural products vs placebo

Acceptability · somatoform disorders in adults

Natural products showed no clear difference in acceptability (all‐cause drop‐outs4) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
RR 0.85 [0.4, 1.78]
3 studies · 506 participants
Low

Natural products vs placebo

Anxiety · somatoform disorders in adults

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 321 participants
Low

Natural products vs placebo

Depression (post‐treatment score on self report and clinician‐rated scales) Different self report and clinician‐rated scales (HDRS, BDI) · somatoform disorders in adults

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 321 participants
Low

Natural products vs placebo

Adverse effects (drop‐outs due to adverse effects4) · somatoform disorders in adults

Natural products showed no clear difference in adverse effects (drop‐outs due to adverse effects4) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
RR 0.54 [0.08, 3.5]
3 studies · 506 participants
Low

Tricyclic antidepressants vs placebo

Acceptability · somatoform disorders in adults

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Natural products vs placebo

Treatment response (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults

It is very uncertain whether natural products changes treatment response (post‐treatment score on self report and… compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only
RR 1.77 [1.34, 2.34]
2 studies · 324 participants
Very low